Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Harmony Biosciences Holdings Inc (HRMY)

Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Harmony Biosciences Holdings Inc 630 W. Germantown Pike Suite 215 Plymouth Meeting PA 19462 USA

www.harmonybiosciences.com Employees: 246 P: 484-539-9800

Description:

Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 1,955,022
Enterprise Value, $K 1,836,932
Shares Outstanding, K 57,031
Annual Sales, $ 582,020 K
Annual Net Income, $ 128,850 K
Last Quarter Sales, $ 186,040 K
Last Quarter Net Income, $ 46,090 K
EBIT, $ 175,300 K
EBITDA, $ 199,220 K
60-Month Beta 0.79
% of Insider Shareholders 30.80%
% of Institutional Shareholders 86.23%
Float, K 39,465
% Float 69.20%
Short Volume Ratio 0.66

Growth:

1-Year Return 6.99%
3-Year Return -21.91%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.79 on 10/29/24
Next Earnings Date N/A
Earnings Per Share ttm 2.11
EPS Growth vs. Prev Qtr 295.00%
EPS Growth vs. Prev Year 25.40%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HRMY Ratios

Ratio
Price/Earnings ttm 16.06
Price/Earnings forward 14.02
Price/Earnings to Growth 0.61
Return-on-Equity % 23.16%
Return-on-Assets % 14.24%
Profit Margin % 22.14%
Debt/Equity 0.31
Price/Sales 3.32
Price/Cash Flow 12.99
Price/Book 3.24
Book Value/Share 10.46
Interest Coverage 8.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar